Kore Potash PLC

Expiry of Unlisted Options

RNS Number : 7506Z
Kore Potash PLC
22 September 2020
 

22 September 2020

 

Kore Potash Plc

("Kore Potash" or the "Company")

 

Expiry of Unlisted Options and Change in Director's Interest Notice

 

The Company wishes to advise that 4,000,000 unlisted options exercisable at £0.11 each expired unexercised on 27 June 2020.

 

Included is a copy of a change in director's interest notice for Mr Hathorn, the Company's Chairman, who held these unlisted options.

 

The Company notes the lodgement of the above is outside the time prescribed by the ASX listing rules. The late lodgement was due to an administrative oversight. The Company and Mr Hathorn is aware of the requirements under ASX Listing Rules 3.19A and 3.19B. The administrative oversight has not affected the Company's current arrangement for ensuring timely notification in accordance with the listing rules.

 

The below change in director's interest notice also reflects the issue of 58,719,906 fully paid ordinary shares to Mr Hathorn following shareholder approval at the Company's recently held General Meeting.

 

ENDS

 

For further information, please visit  www.korepotash.com  or contact:

 

Kore Potash

Brad Sampson - CEO

 


Tel: +27 11 469 9140

Tavistock Communications

Jos Simson

Edward Lee

 


Tel: +44 (0) 20 7920 3150

Canaccord Genuity - Nomad and Broker

James Asensio

Henry Fitzgerald-O'Connor

 


Tel: +44 (0) 20 7523 4600

Shore Capital - Joint Broker

Jerry Keen

Toby Gibbs

Mark Percy


Tel: +44 (0) 20 7408 4050

 



 

Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01  Amended 01/01/11

 

Name of Entity

Kore Potash Plc (ASX, AIM, JSE : KP2)

ARBN

621 843 614

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. 

 

Name of Director

David Andrew Hathorn

Date of Last Notice

7 April 2020

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of)

Date of change

21 September 2020

No. of securities held prior to change

 

54,457,146 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021

 

 

500,000 Performance Rights each expiring 22 May 2022

 

4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020

Held in the name of

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Direct

 

 

Direct

Class

Unlisted Options and Fully Paid Ordinary Shares (AIM)

Number acquired

58,719,906 Fully Paid Ordinary Shares (AIM)

Number disposed

4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020 (expired unexercised)

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

£0.0065 per Share

No. of securities held after change

 

54,457,146 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021

 

 

 

29,359,953 Fully Paid Ordinary Shares (AIM Listed)

 

 

29,359,953 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

 

500,000 Performance Rights each expiring 22 May 2022

Held in the name of

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of)

 

Direct

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

(i) Participation in Placement as approved at the Company's General Meeting on 18 September 2020 (refer to Resolution 3)

(ii)  Expiry of Unlisted Options

 

Part 2 - Change of director's interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder

(if issued securities)

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

N/A

Interest after change

N/A

 

Part 3 - + Closed period

 

Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKBBNDBKDFCB